Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Efficacy and Safety Study of Oral CEM-101 Compared to Oral Levofloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia

ClinicalTrials.gov ID: NCT01168713

Public ClinicalTrials.gov record NCT01168713. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 4:50 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Multi-Center Study to Evaluate the Efficacy and Safety of Oral CEM-101 Compared to Oral Levofloxacin in the Treatment of Patients With Community-Acquired Bacterial Pneumonia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Study to evaluate the safety and efficacy of oral CEM-101 compared to oral Levofloxacin in the treatment of adults with moderate to moderately severe community-acquired bacterial pneumonia.

Study identification

NCT ID
NCT01168713
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Melinta Therapeutics, Inc.
Industry
Enrollment
132 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2010 (Type not available)
Primary completion
Jul 2011 (Actual)
Completion
Jul 2011 (Actual)
Last update posted
Mar 3, 2017

2010 – 2011

United States locations

U.S. sites
45
U.S. states
22
U.S. cities
44
Facility City State ZIP Site status
Not listed Birmingham Alabama 35242 —
Not listed Flagstaff Arizona 86001 —
Not listed Bell Gardens California 90201 —
Not listed Chula Vista California 91911 —
Not listed LeMesa California 91942 —
Not listed Los Angeles California 90015 —
Not listed Montclaire California 91763 —
Not listed Norwalk California 90650 —
Not listed Oceanside California 92056 —
Not listed Oxnard California 93030 —
Not listed Pasadena California 91105 —
Not listed Torrence California 90501 —
Not listed Waterbury Connecticut 06708 —
Not listed DeBary Florida 32713 —
Not listed Gainesville Florida 32605 —
Not listed Hialeah Florida 33012 —
Not listed Kissimmee Florida 34741 —
Not listed Orlando Florida 32837 —
Not listed Blue Ridge Georgia 30513 —
Not listed Columbus Georgia 31904 —
Not listed Savannah Georgia 31406 —
Not listed Idaho Falls Idaho 83404 —
Not listed Morton Illinois 61550 —
Not listed Dubuque Iowa 52001 —
Not listed New Orleans Louisiana 70112 —
Not listed Fall River Massachusetts 02720 —
Not listed New Bedford Massachusetts 02740 —
Not listed Detroit Michigan 48202 —
Not listed Traverse City Michigan 49684 —
Not listed Butte Montana 59701 —
Not listed Las Vegas Nevada 89109 —
Not listed Akron Ohio 44304 —
Not listed Carlisle Ohio 45005 —
Not listed Eugene Oregon 97404 —
Not listed West Reading Pennsylvania 19611 —
Not listed Simpsonville South Carolina 29681 —
Not listed Rapid City South Dakota 57702 —
Not listed Franklin Tennessee 37067 —
Not listed Corsicana Texas 75110 —
Not listed Houston Texas 77002 —
Not listed Houston Texas 77093 —
Not listed San Antonio Texas 78238 —
Not listed Draper Utah 84020 —
Not listed Magna Utah 84044 —
Not listed Salt Lake City Utah 84121 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01168713, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 3, 2017 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01168713 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →